Project Grant HT94252410355
Award Date 5/1/24
Completion Date 4/30/27
Dollars Obligated $840K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- This federal Project Grant award of $1,496,576.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research by Baylor College of Medicine to develop therapies for classical Ehlers-Danlos syndrome. The award commences on September 1, 2025 with an ultimate completion date of August 31, 2029. As a prestigious private, non-profit health sciences university, Baylor College of Medicine has extensive...
- The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
- This $802,500 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides funding to Baylor College of Medicine in Houston, TX for preclinical gene therapy studies in a mouse model of TSC2. The award period runs from May 1, 2025 to April 30, 2028. As a prestigious private non-profit health sciences university, Baylor College of Medicine has extensive expertise in biomedical research, clinical trials, and specialized...
- The U.S. Department of Defense, Defense Health Agency has awarded a $918,000 Project Grant to the Texas A&M University System Health Science Center to conduct research on "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". This 3-year grant, running from September 15, 2024 to September 14, 2027, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to investigate basic and translational research on the role...
- This $1,229,872 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support a 3-year study by Baylor College of Medicine on the clinical and genetic architecture of autism spectrum disorder among individuals with tuberous sclerosis complex. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of this neurological condition. The project...
- This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
- The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to...
- This $1,543,430 federal Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to target thromboinflammation in rheumatoid arthritis. The award was made to Baylor College of Medicine, a leading academic medical center in Houston, Texas, on May 15, 2024, with a period of performance through May 14, 2028. The grant enables Baylor to conduct innovative biomedical research focused on improving health outcomes...
- The Department of the Army Medical Command awarded a $909,291 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M University System Health Science Center, Finance And Business Services Division for the project "INNATE AND ADAPTIVE IMMUNE MECHANISMS OF CD74 IN POST-TRAUMATIC EPILEPSY". The grant will fund research over a 3-year period from Sep 2024 to Sep 2027 to investigate the role of the CD74 protein in the development of...
- Federal Grant Award Summary Texas A&M University System Health Science Center received a $1.001 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), with an award date of September 30, 2025, and a completion date of September 29, 2028. The project, titled "Endocannabinoid Mechanisms of Post-Traumatic Epilepsy," supports advanced biomedical research investigating the cellular and molecular...